Protagonist Therapeutics Inc (PTGX)

Quick ratio

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash US$ in thousands 186,727 125,744 123,665 117,358 33,006
Short-term investments US$ in thousands 154,890 111,611 203,235 188,500 100,011
Receivables US$ in thousands 3,852 5,333 3,821 7,499
Total current liabilities US$ in thousands 21,274 31,179 44,016 40,241 35,406
Quick ratio 16.06 7.74 7.55 7.70 3.97

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($186,727K + $154,890K + $—K) ÷ $21,274K
= 16.06

The quick ratio of Protagonist Therapeutics Inc has shown a generally increasing trend over the past five years, indicating an improvement in the company's ability to meet its short-term obligations with its most liquid assets. The quick ratio has increased from 3.97 in 2019 to 16.06 in 2023. This suggests that the company has significantly more current assets that can be quickly converted into cash to cover its current liabilities.

A quick ratio above 1 indicates that a company has an adequate level of liquid assets to cover its short-term liabilities. Protagonist Therapeutics Inc's quick ratio has consistently been well above 1 over the years, reflecting a strong liquidity position.

The increase in the quick ratio from 2019 to 2023 may indicate effective management of working capital, improved cash flow management, or increased cash reserves. Investors and creditors generally view a high quick ratio positively as it signifies a company's ability to handle its financial obligations without relying heavily on selling inventory or obtaining additional financing.

Overall, the upward trend in Protagonist Therapeutics Inc's quick ratio indicates a healthy liquidity position and a lower risk of financial distress in meeting its short-term obligations.


Peer comparison

Dec 31, 2023